Obstructive Sleep Apnea Syndrome Exacerbates NASH Progression via Selective Autophagy‐Mediated Eepd1 Degradation

Jie Xiong,Ying Xu,Ning Wang,Shengming Wang,Yao Zhang,Sijia Lu,Xiaoman Zhang,Xingxing Liang,Chuchu Liu,Quanxin Jiang,Junting Xu,Qiqi Qian,Peihui Zhou,Limin Yin,Feng Liu,Suzhen Chen,Shankai Yin,Junli Liu

DOI: https://doi.org/10.1002/advs.202405955

IF: 15.1

2024-06-26

Advanced Science

Abstract:Chronic intermittent hypoxia increases the expression of Hif1α, and Hif1α promotes autophagy activation in hepatocytes, which accelerates the autophagic degradation of Eepd1, a DNA repair enzyme, and hence exacerbates DNA damage in hepatocytes. The increased DNA damage exacerbates liver inflammation, fibrosis, and NASH progression. Eepd1 liver‐specific knockout mice aggravate DNA damage and then exacerbate liver inflammation, fibrosis, and NASH progression. Retigabine dihydrochloride, targeting CIH‐mediated Eepd1 degradation, can represent an effective treatment for CIH‐induced NASH. Obstructive sleep apnea syndrome (OSAS), characterized by chronic intermittent hypoxia (CIH), is an independent risk factor for aggravating non‐alcoholic steatohepatitis (NASH). The prevailing mouse model employed in CIH research is inadequate for the comprehensive exploration of the impact of CIH on NASH development due to reduced food intake observed in CIH‐exposed mice, which deviates from human responses. To address this issue, a pair‐feeding investigation with CIH‐exposed and normoxia‐exposed mice is conducted. It is revealed that CIH exposure aggravates DNA damage, leading to hepatic fibrosis and inflammation. The analysis of genome‐wide association study (GWAS) data also discloses the association between Eepd1, a DNA repair enzyme, and OSAS. Furthermore, it is revealed that CIH triggered selective autophagy, leading to the autophagic degradation of Eepd1, thereby exacerbating DNA damage in hepatocytes. Notably, Eepd1 liver‐specific knockout mice exhibit aggravated hepatic DNA damage and further progression of NASH. To identify a therapeutic approach for CIH‐induced NASH, a drug screening is conducted and it is found that Retigabine dihydrochloride suppresses CIH‐mediated Eepd1 degradation, leading to alleviated DNA damage in hepatocytes. These findings imply that targeting CIH‐mediated Eepd1 degradation can be an adjunctive approach in the treatment of NASH exacerbated by OSAS.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry